Kyverna Therapeutics, Inc. KYTX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s operating lease ROU assets?
- Kyverna Therapeutics, Inc. (KYTX) reported operating lease ROU assets of $8.19M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Kyverna Therapeutics, Inc.'s operating lease ROU assets increased by 42.1% year-over-year, from $5.76M to $8.19M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s operating lease ROU assets?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s operating lease ROU assets has grown at a -25.9% compound annual growth rate (CAGR), from $6.49M to $3.57M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.